Adverum Biotechnologies Inc. (ADVM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Adverum Biotechnologies I...

    NASDAQ: ADVM · Real-Time Price · USD
    3.31
    -0.16 (-4.61%)
    At close: Sep 10, 2025, 3:59 PM
    3.28
    -0.91%
    After-hours: Sep 10, 2025, 07:16 PM EDT

    Adverum Biotechnologies Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1M 3.6M n/a 7.5M
    Cost of Revenue
    		 3.65M 5.64M 6.53M 4.64M
    Gross Profit
    		 -2.65M -2.04M -6.53M 2.85M
    Operating Income
    		 -153.16M -128.94M -155.01M -145.06M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -130.93M -123.19M -154.46M -145.54M
    Net Income
    		 -130.93M -122.12M -154.54M -145.54M
    Selling & General & Admin
    		 63.12M 49.91M 57.86M 64.44M
    Research & Development
    		 77.04M 77.48M 99.28M 89.18M
    Other Expenses
    		 n/a 5.15M -8.65M -5.71M
    Operating Expenses
    		 140.16M 132.54M 148.48M 147.91M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 154.16M 132.54M 155.01M 152.56M
    Income Tax Expense
    		 n/a -1.08M 74K n/a
    Shares Outstanding (Basic)
    		 19.78M 57.98M 57.98M 98.36M
    Shares Outstanding (Diluted)
    		 19.78M 57.98M 57.98M 98.36M
    EPS (Basic)
    		 -6.62 -2.02 -2.67 -1.48
    EPS (Diluted)
    		 -6.62 -2.02 -2.67 -1.48
    EBITDA
    		 -127.27M -117.55M -147.93M -140.9M
    EBIT
    		 -130.93M -123.19M -154.46M -146.12M
    Depreciation & Amortization
    		 3.65M 5.64M 6.53M 4.64M

    Add to Watchlist